investordatabase.org

Versant Ventures

versantventures.com Direct investor

Versant Ventures is a venture capital firm that invests in biotechnology and life sciences companies. It manages over $5.5 billion and has a team with extensive experience in venture capital, pharma, and biotech.

Versant Ventures is a venture capital firm headquartered in San Francisco, United States, founded in 1999. It invests directly in companies, from seed to growth, in biotech, biotechnology, pharma and life sciences. $5.5B under management, as it reports.

“HARNESSING THE POWER OF SCIENCE, GLOBALLY”

Versant Ventures, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedGrowth
Headquarters
San Francisco, United States
Invests in
global
Sectors
biotech, biotechnology, pharma, life sciences
Founded
1999
Assets under management
$5.5B

Team, as Versant Ventures publishes it

  • Brad Bolzon Chairman, Managing Director
  • Jerel Davis Managing Director
  • Alex Mayweg Managing Director
  • Clare Ozawa Managing Director
  • Carlo Rizzuto Managing Director
  • Tom Woiwode Managing Director
  • Markus Enzelberger Partner
  • Nigel Sheail Partner
  • Peter Emtage Venture Partner
  • Richard Glynne Venture Partner
  • Kevin Grove Venture Partner
  • Rami Hannoush Venture Partner

Names and roles exactly as listed on versantventures.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 49 co-investors found.

and 39 more — the graph.

Where this comes from

Every fact above was read from a page Versant Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 1031 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under